Literature DB >> 2828275

A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine.

M R Zalutsky1, A S Narula.   

Abstract

A procedure is described for the radioiodination of proteins using an iodinated derivative of N-succinimidyl 3-(tri-n-butylstannyl) benzoate (ATE). Adequate removal of unreacted ATE from [125I]ATE was necessary for optimal protein radioiodination. Labeling efficiencies of greater than 60% could be obtained after a 20 min incubation of goat IgG with [125I]ATE at 4 degrees C. Paired-label experiments with goat IgG labeled with 125I using ATE and 131I using Iodogen demonstrated that use of the ATE reagent for protein labeling significantly reduced (P less than 0.005) the thyroid uptake of radioiodine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2828275     DOI: 10.1016/0883-2889(87)90069-4

Source DB:  PubMed          Journal:  Int J Rad Appl Instrum A        ISSN: 0883-2889


  22 in total

1.  MRI/SPECT/Fluorescent Tri-Modal Probe for Evaluating the Homing and Therapeutic Efficacy of Transplanted Mesenchymal Stem Cells in a Rat Ischemic Stroke Model.

Authors:  Yaohui Tang; Chunfu Zhang; Jixian Wang; Xiaojie Lin; Lu Zhang; Yi Yang; Yongting Wang; Zhijun Zhang; Jeff W M Bulte; Guo-Yuan Yang
Journal:  Adv Funct Mater       Date:  2015-02-18       Impact factor: 18.808

2.  [(18)F]Fluorobenzoyllysinepentanedioic Acid Carbamates: New Scaffolds for Positron Emission Tomography (PET) Imaging of Prostate-Specific Membrane Antigen (PSMA).

Authors:  Xing Yang; Ronnie C Mease; Mrudula Pullambhatla; Ala Lisok; Ying Chen; Catherine A Foss; Yuchuan Wang; Hassan Shallal; Hannah Edelman; Adam T Hoye; Giorgio Attardo; Sridhar Nimmagadda; Martin G Pomper
Journal:  J Med Chem       Date:  2015-12-16       Impact factor: 7.446

Review 3.  Approaches to radiolabeling of antibodies for diagnosis and therapy of cancer.

Authors:  A R Fritzberg; R W Berninger; S W Hadley; D W Wester
Journal:  Pharm Res       Date:  1988-06       Impact factor: 4.200

4.  Comparison of succinimidyl [(125)I]iodobenzoate with iodogen iodination methods to study pharmacokinetics and ADME of biotherapeutics.

Authors:  Jianqing Chen; Mengmeng Wang; Alison Joyce; David DeFranco; Mania Kavosi; Xin Xu; Denise M O'Hara
Journal:  Pharm Res       Date:  2014-05-21       Impact factor: 4.200

5.  Radioimmunotherapy: no news from the newcomer.

Authors:  A M Mello; E K Pauwels; F J Cleton
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

6.  Labeling monoclonal antibodies and F(ab')2 fragments with the alpha-particle-emitting nuclide astatine-211: preservation of immunoreactivity and in vivo localizing capacity.

Authors:  M R Zalutsky; P K Garg; H S Friedman; D D Bigner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

7.  In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.

Authors:  Carlos Pérez-Medina; Tina Binderup; Mark E Lobatto; Jun Tang; Claudia Calcagno; Luuk Giesen; Chang Ho Wessel; Julia Witjes; Seigo Ishino; Samantha Baxter; Yiming Zhao; Sarayu Ramachandran; Mootaz Eldib; Brenda L Sánchez-Gaytán; Philip M Robson; Jason Bini; Juan F Granada; Kenneth M Fish; Erik S G Stroes; Raphaël Duivenvoorden; Sotirios Tsimikas; Jason S Lewis; Thomas Reiner; Valentín Fuster; Andreas Kjær; Edward A Fisher; Zahi A Fayad; Willem J M Mulder
Journal:  JACC Cardiovasc Imaging       Date:  2016-05-25

Review 8.  Quantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imaging.

Authors:  Kenneth M Tichauer; Yu Wang; Brian W Pogue; Jonathan T C Liu
Journal:  Phys Med Biol       Date:  2015-07-02       Impact factor: 3.609

Review 9.  Tissue distribution studies of protein therapeutics using molecular probes: molecular imaging.

Authors:  Simon-Peter Williams
Journal:  AAPS J       Date:  2012-03-31       Impact factor: 4.009

10.  D-Amino acid peptide residualizing agents bearing N-hydroxysuccinimido- and maleimido-functional groups and their application for trastuzumab radioiodination.

Authors:  Marek Pruszynski; Eftychia Koumarianou; Ganesan Vaidyanathan; Satish Chitneni; Michael R Zalutsky
Journal:  Nucl Med Biol       Date:  2014-08-13       Impact factor: 2.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.